X0206 3 2022-11-09 0 0001781174 Acrivon Therapeutics, Inc. ACRV 0001950573 Devroe Eric C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 0 1 0 0 Chief Operating Officer Common Stock 20275 D Stock Option (Right to Buy) 1.04 2031-01-13 Common Stock 105840 D Stock Option (Right to Buy) 3.88 2032-04-05 Common Stock 94586 D The original grant was for 126,115 shares, which was partially exercised for 20,275 shares of common stock. Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. The shares subject to the option vested or shall vest quarterly on the last day of each quarter for 16 quarters following January 1, 2022, in each case subject to the Reporting Person's continuous service through each such vesting date. Exhibit List - Exhibit 24 - Power of Attorney /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2022-11-09